The Controversial History of Hormone Replacement Therapy

被引:129
作者
Cagnacci, Angelo [1 ]
Venier, Martina [1 ]
机构
[1] Azienda Sanit Univ Integrata, Obstet & Gynecol Unit, I-33100 Udine, Italy
来源
MEDICINA-LITHUANIA | 2019年 / 55卷 / 09期
关键词
hormone replacement therapy; osteoporosis; breast cancer; cardiovascular disease; BREAST-CANCER INCIDENCE; CORONARY-HEART-DISEASE; ESTROGEN PLUS PROGESTIN; POSTMENOPAUSAL WOMEN; ENDOMETRIAL CANCER; MEDROXYPROGESTERONE ACETATE; CARDIOVASCULAR-DISEASE; ENDOTHELIAL FUNCTION; FRACTURE INCIDENCE; RANDOMIZED-TRIAL;
D O I
10.3390/medicina55090602
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The history of hormone replacement therapy (HRT) started in the 1960s, with very high popularity in the 1990s. The first clinical trials on HRT and chronic postmenopausal conditions were started in the USA in the late 1990s. After the announcement of the first results of the Women's Health Initiative (WHI) in 2002, which showed that HRT had more detrimental than beneficial effects, HRT use dropped. The negative results of the study received wide publicity, creating panic among some users and new guidance for doctors on prescribing HRT. The clear message from the media was that HRT had more risks than benefits for all women. In the following years, a reanalysis of the WHI trial was performed, and new studies showed that the use of HRT in younger women or in early postmenopausal women had a beneficial effect on the cardiovascular system, reducing coronary disease and all-cause mortality. Notwithstanding this, the public opinion on HRT has not changed yet, leading to important negative consequences for women's health and quality of life.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Current perspectives on benefits and risks of hormone replacement therapy
    Burkman, RT
    Collins, JA
    Greene, RA
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2001, 185 (02) : S13 - S23
  • [32] Latest evidence on using hormone replacement therapy in the menopause
    Bakour, Shagaf H.
    Williamson, Jennifer
    OBSTETRICIAN & GYNAECOLOGIST, 2015, 17 (01) : 20 - 28
  • [33] The risks of avoiding hormone replacement therapy during menopause
    Enrique Blumel, Juan
    Arteaga, Eugenio
    REVISTA MEDICA DE CHILE, 2017, 145 (06) : 760 - 764
  • [34] Changes in Fertility and Hormone Replacement Therapy in Kidney Disease
    Holley, Jean L.
    Schmidt, Rebecca J.
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2013, 20 (03) : 240 - 245
  • [35] Long-term hormone replacement therapy use is no longer controversial
    Palacios, S
    MIDLIFE HEALTH - CURRENT CONCEPTS AND CHALLENGES FOR THE FUTURE, 2002, 1229 : 127 - 131
  • [36] Hormone replacement therapy in gynecologic cancer survivors: Why not?
    Ibeanu, Okechukwu
    Modesitt, Susan C.
    Ducie, Jennifer
    von Gruenigen, Vivian
    Agueh, Modupe
    Fader, Amanda Nickles
    GYNECOLOGIC ONCOLOGY, 2011, 122 (02) : 447 - 454
  • [37] The WHI: the effect of hormone replacement therapy on fracture prevention
    de Villiers, T. J.
    Stevenson, J. C.
    CLIMACTERIC, 2012, 15 (03) : 263 - 266
  • [38] Systematic review about breast cancer incidence in relation to hormone replacement therapy use
    Antoine, C.
    Ameye, L.
    Paesmans, M.
    Rozenberg, S.
    CLIMACTERIC, 2014, 17 (02) : 116 - 132
  • [39] Back to the future: Hormone replacement therapy as part of a prevention strategy for women at the onset of menopause
    Lobo, Roger A.
    Pickar, James H.
    Stevenson, John C.
    Mack, Wendy J.
    Hodis, Howard N.
    ATHEROSCLEROSIS, 2016, 254 : 282 - 290
  • [40] Bias from depletion of susceptibles: the example of hormone replacement therapy and the risk of venous thromboembolism
    Renoux, Christel
    Dell'Aniello, Sophie
    Brenner, Benjamin
    Suissa, Samy
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 (05) : 554 - 560